Fluticasone Propionate Nasal Spray Usp

Fluticasone Propionate Nasal Spray Usp

Many readers are interested in the appropriate subject: information about fluticasone spray regarding prescriptions. We are happy to report that the manufacturer has already done a study of current research on your fascinating subject. We can give you a wide range of answers based on the latest medical reports, advanced research papers, and sample survey information. Find out more.

Disruption of wound healing: due to the inhibitory effect of corticosteroids on wound healing, patients recently. nasal ulcers, nasal surgery, or nasal Trauma should use it fluticasone propionate nasal spray to recover.

Fluticasone nasal

Generic name: fluticasone nasal [floo-tik-a-sone] Brand: Flonase, Veramyst, Xhanance, Children’s Flonase, Sensimist Flonase,. all 9 brands. Flonase Allergy Lighting, Sensible Value Nasoflor, Children’s Allergy Lighting Sensible Value, Not Bad Value Dosage (Fluticasone) Form: nasal spray (27, 5 mcg/im.

Medical Test Med. Com December 20, 2022. authored by CernerMultum.

What is fluticasone nasal ?

Fluticasone nasal (for the nose) is a steroidal drug used to treat nasal blocked, sneezing, sneezing, runny, itchy or runny nose all year round seasonally or as a result of allergies.



The Xhance brand of fluticasone nasal For use in adults only. Veramyst may be used in children under 2 years of age. flonase for use in adults and children under 4 years of age.

Fluticasone nasal May continue to be used for purposes not listed in this Medication Guide.

Warning.

Follow all directions on your own medication label and package. Tell all care providers about all illnesses, allergies, and all medications you use.

before you take this medication.

You should not use fluticasone nasal If you are allergic to it.

Fluticasone may weaken your immune system, which could worsen any infections you already have or have not had with it. Tell your doctor about any illnesses or infections you have had for the last few months.

Tell your doctor if you ever have

  • Aches or pains inside your nose.
  • Trauma or surgery to the nose; or
  • Glaucoma or cataracts; and
  • Liver disease; or
  • Diabetes; or
  • Weak immune system; or
  • Any type of infection (bacterial, fungal, viral, or parasitic).

If you use fluticasone nasal Ask your doctor or pharmacist if you have a medical condition without a prescription. if fluticasone nasal is safe for you.

Tell your doctor if you are pregnant or breastfeeding.

How should I use fluticasone nasal ?

Follow all instructions on your own prescription label and read all medication instructions or package leaflets. Use the medication literally as prescribed.



Do not share this medication with anyone else. Do not share with others, even if you have the same symptoms.

Your dosage will depend on the the fluticasone brand or possibility of use, and your dose may change as your symptoms improve. Follow all dosing instructions exactly.

A child using the nasal spray Adults should maintain

Read all instructions for using your medication and follow them carefully. Ask your doctor or pharmacist if you know these instructions.

Shake the nasal spray Each time you use.

If you switched to fluticasone You do not need to stop using your steroid medication at any time. Follow your doctor’s instructions to lower your dose.

Borrow for a few days before your symptoms improve. Continue to use the medication as prescribed and let your doctor know if your symptoms do not improve after one week.

Store fluticasone nasal Keep away from moisture and heat, to room temperature. Throw the spray bottle after use. 120 sprays even if there is still drink in the bottle.

What happens if I miss a dose?

Use the drink as soon as possible, but skip the missed dose in case it is time for the correct dose. Do not use two doses at the same time.

What happens if I overdose?

Find appropriate medical help or call the GIF Helpline at 1-800-222-1222.

An overdose of fluticasone nasal Life-threatening symptoms are not expected. Prolonged use of steroid medications can lead to glaucoma, cataracts, thin skin, bruising, changes in body fat (especially face, neck, back, and hips), facial acne or hair growth, menstrual problems, impotence or loss from interest in sex.

What to ignore when using fluticasone nasal ?

Avoid getting the spray in your eyes or your mouth. When this happens, it is with water.

Avoid being near sick or infected people. If you are affected by chicken po or measles, call your own doctor for preventive treatment. These situations are, fluticasone nasal .

Fluticasone nasal side effects

Call for medical emergency assistance if you show symptoms of an allergic reaction: hives, skin rash; dizziness; rough breathing; swelling of the face, lips, tongue, or throat.

Fluticasone nasal Can cause serious side effects. Call your own doctor immediately if you are suffering from:

  • Serious or persistent nosebleeds;.
  • Noisy breathing around your nostrils, watery mouth, or crust formation.
  • Redness, soreness, or white spots in your mouth or throat.
  • Fever, tremors, or body aches.
  • Blurred vision, eye pain, or seeing halos around lights.
  • Wounds that do not want to heal. Or
  • Signs of a hormonal disorder – fatigue or helplessness, dizziness, light in head, nausea.

Steroid medications can affect the child’s lifting. Tell the doctor if the baby does not increase at a normal pace when using fluticasone nasal .

Common side effects of fluticasone nasal may include:

  • Light bleeding, flying or itchy nose.
  • Sore or white spots inside or around the nose.
  • Cough, difficulty breathing.
  • Headache, back pain.
  • Sinus pain, sore throat, fever; or
  • Nausea, nausea.

This is not an absolute list of side effects, and there is a good chance that other side effects may occur. Ask your own doctor about side effects; you can report side effects to the FDA at 1-800-FDA-1088.

Fluticasone nasal dosing information

Normal adult dosage for rhinitis:

Fluticasone furoate: 2 sprays (27.5 mcg/ spray (fluticasone in the nostrils once daily) propionate : 1 or 2 sprays (50 mcg/ spray ) Once a day in all nostrils, as needed.

Use: Curing signs of seasonal and long-term allergic rhinitis

Usual dosage for pediatric rhinitis:

2-11 years: Fluticason Furoate: 1 spray (27.5 mcg/ spray (once a day in all nostrils)

4-11 years: Fluticasone. propionate : 1 spray (50 mcg/ spray (once a day in all nostrils)

12 years and older: Fluticason Furoate: 2 sprays (27.5 mcg/ spray (fluticasone in the nostrils once daily) propionate : 1 or 2 sprays (50 mcg/ spray ) Once a day in all nostrils, as needed.

Use: Curing signs of seasonal and long-term allergic rhinitis

Other medications affected fluticasone nasal ?

Tell your doctor about all other medications, especially

  • Bacteria-resistant medications; or
  • antiviral drugs to cure hepatitis C or HIV/AIDS.

This list is not complete. Other medications may affect your health. fluticasone nasal These are medications that are freely available with prescription drugs, vitamins, and herbal products. Not all possible interactions between medications are listed here.

More about fluticasone nasal

  • Please review the interactions
  • Compare alternatives
  • Prices and Coupons
  • Reviews (316)
  • Recent FDA Warnings (1)
  • Side Effects
  • Dosing Information
  • Advice for Patients
  • Pregnancy
  • Drug class: nasal steroids
  • In Spanish

Patient Source

  • Advanced Reading
  • Fluticasone Nasal Spray
  • Fluticasone Nasal Spray (Ex-expiration date)

Prescription for information about Fluticasone Nasal Spray.

Drug Medical Testing. com. last updated on November 21, 2022.

On this page.
  • Indications and Use
  • Medication and Administration
  • Dosage Forms and Strengths
  • Contraindications
  • Warnings and Precautions
  • Side Effects
  • Drug Interactions
  • Use in specific populations
  • Overdose
  • Description
  • Clinical pharmacology
  • Non-clinical toxicology
  • Clinical Research
  • Delivery/ Preservation and Treatment Methods
  • Information on Patient Guidance

Fluticasone Nasal Spray Indications and Dosing

Fluticasone propionate nasal spray Treatment is indicated for the nasal Symptoms of long-term nonallergic marginal inflammation in adult and pediatric patients 4 years of age and older.

Related/similar medications

Fluticasone dosage and authority and administration

Administer fluticasone propionate nasal spray Only via the nasal route. Leading fluticasone propionate nasal spray After the first time or period of non-use (more than 1 week), shake the contents well and run away in the air, away from the face. 6 sprays Aerial, away from face. Shake fluticasone propionate nasal spray Use caution with each use.

Patients should use fluticasone propionate nasal spray Shake carefully after each use, as effectiveness depends on continued use. It may take several days for maximum effect to occur, and individual patients will experience different initial periods and varying degrees of symptom relief.

Adults

Recommended starting dose for adults 2 sprays (50 mcg of fluticasone propionate Each once daily in the nostrils (total daily dose, 200 µg). Same total daily dose, 1 spray twice daily (8 am in the morning, 8 pm in the evening) in each nostril is still effective. After the first few days, patients have the opportunity to reduce the dosage 1 spray once daily in all nostrils for maintenance therapy.

The maximum total daily dose may not exceed 2 sprays all nostrils (total dose, 200 µg/day). There is little evidence that exceeding the correct dose is more effective.

Adolescents and young children (from 4 years of age)

Recommended starting dose for adolescents and children from 4 years of age 1 spray Once daily in all nostrils (total daily dose, 100 µg/day). Patients do not respond adequately 1 spray Allow use in any nostril 2 sprays Once daily in all nostrils (total daily dose, 200 µg). Dose should be reduced after adequate control is reached 1 spray Once daily in all nostrils.

Maximum total daily dose may not be exceeded 2 sprays All nostrils (200 µg/day). There is little evidence that exceeding the correct dose is more effective.

Dosage Forms and Strengths

Fluticasone propionate nasal spray USP is aqua suspension.100 per mg spray delivers 50 mcg of fluticasone propionate USP.

Contraindications

Fluticasone propionate nasal spray Prohibited in patients with hypersensitivity to one of the components [see Warnings and Precautions (5. 3), Description (11)].

Warnings and Precautions

Topical Nasal Effects

Epistaxis: In clinical studies of 2 to 26 months, feigning was observed more frequently among treated subjects than among those who received placebo [see Warnings and Precautions (5. 3), Description (11)]. fluticasone propionate nasal spray Then with those who received placebo [see Adverse Reactions (6. 1)].

Nasal ulcers: postmarketing cases of nasal nhesulceration was observed in patients treated fluticasone propionate nasal spray [see Adverse Reactions (6. 2)].

Candida infection: in clinical studies fluticasone propionate Intranasal has done local Candida albicans nasal and throat infections. If this infection occurs, treatment with appropriate neighborhood therapy and cessation may be necessary. of fluticasone propionate nasal spray . Patients using fluticasone propionate nasal spray If the patient suffers for more than a few months, he/she should be examined from time to time for indications of Candida infection or other symptoms adversely affecting the throat. the nasal mucosa.

Neuusteussenschot perforation: a post-market case of nasal Neuusteusschot perforation has been reported in treated patients fluticasone propionate nasal spray [see Adverse Reactions (6. 2)].

Disruption of wound healing: due to the inhibitory effect of corticosteroids on wound healing, patients recently. nasal ulcers, nasal surgery, or nasal Trauma should use it fluticasone propionate nasal spray to recover.

Glaucoma and cataracts.

The use of nasal and inhaled corticosteroids can lead to the development of glaucoma and/or cataracts. Therefore, a history of visual changes or increased intraocular pressure, glaucoma, and/or cataracts should be carefully prognosticated in patients. Consider the probability of referral to an ophthalmologist in patients who develop ocular symptoms or ocular hypersensitivity reactions. use fluticasone propionate nasal spray long-term .

Hypersensitivity reactions, including anaphylaxis.

Hypersensitivity reactions (e.g., anaphylaxis, angioedema, ur measles, contact dermatitis, skin rash) have been reported since use. of fluticasone propionate nasal spray . Discontinue fluticasone propionate nasal spray If these reactions occur [see contraindications (4)]. Immediate hypersensitivity reactions may occur after administration. of fluticasone propionate nasal spray .

Immunosuppression.

People who use substances that suppress the immune system are more susceptible to infections than healthy individuals. For example, chicken and measles are more likely to be of serious or fatal course in sensitive children and adults who use corticosteroids. In those children and adults who have not received these diseases or who have not been adequately vaccinated, special precautions are recommended to prevent contamination. It is not clear how the dose, method, and duration of corticosteroid administration affect the risk of disseminated infection. Previous treatment with corticosteroids for the contribution and/or risk of underlying disease is not yet known. If the patient has passed water cell, prophylaxis including water cell herpes zoster immunoglobulin (VZIG) may be indicated. If the patient maintains measles, prophylaxis combined with intramuscular immunoglobulin (IG) may be indicated (see complete information on the purpose of Vzig and Ig). If chicken develops, treatment with antiviral agents can be considered.

In patients with severe respiratory TB, nasal corticosteroids should be used cautiously if already used. Systemic fungal, bacterial, viral, or parasitic infections; or ocular herpes simplex.

Hypercortical and adrenal suppression

Systemic corticosteroid effects such as cortical hyperplasia and adrenal suppression may occur if nasal corticosteroids are administered at higher than appropriate doses or in sensitive individuals. If these configurations occur, the dosage should be adjusted of fluticasone propionate nasal spray Oral corticosteroids should be discontinued slowly, following the usual procedures for discontinuation of oral corticosteroids.

Replacing systemic corticosteroids with topical corticosteroids may cause symptoms of adrenal insufficiency. In addition, some patients may experience signs of corticosteroid withdrawal (e.g., joint and muscle pain, fatigue, and depression). Patients previously receiving long-term systemic corticosteroids and switched to topical corticosteroids should be closely monitored for acute adrenal insufficiency in response to stress. In patients with asthma or other clinical conditions requiring long-term treatment with systemic corticosteroids, abrupt reductions in systemic corticosteroid doses may result in substantial worsening of symptoms.

Drug Interactions with Potent Cytochrome P450 3A4 Inhibitors

Strong cytochrome P450 3A4 (CYP3A4) inhibitors (e.g., ritonavir, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir, ketoconazole, telithromycin, Conivaptan, lopinavir, nefazodone, voriconazole) are not recommended. and systemic corticosteroids [see Warnings and Precautions [see Warnings and Precautions]] because they may aggravate systemic corticosteroid side effects. fluticasone propionate nasal spray Not recommended because it may aggravate systemic corticosteroid side effects [see Drug Interactions [see Drug Interactions]]. Drug Interactions (7. 1), Clinical Pharmacology (12. 3)].

Effects on Growth

Administration of nasal corticosteroids to pediatric patients may cause a reduction in growth rate (see Use in Select Populations (8. 4)). Monitor the rate of increase in pediatric patients on a regular basis. fluticasone propionate nasal spray Use of nasal corticosteroids To minimize the systemic effects of nasal corticosteroids fluticasone propionate nasal spray Titrate each patient’s dose to the lowest dose that effectively controls each patient’s symptoms [see “Pharmacology and Dosing” in this section]. Dosage and Administration” (2) and “Use in Specific Populations” (8. 4)).

Adverse Effects

Systemic and topical use of corticosteroids may result in the following

• Epistaxis, nasal Ulceration, Candida albicans infection, nasal hypercorticism and adrenal suppression [see Warnings and Precautions (5. 5)] – exposure to lifting [see Warnings and Precautions (5. 7)].

Clinical Trial Experience

Because clinical studies are conducted in a variety of settings, the side effect characteristics observed in a clinical study of a product may not be immediately comparable to those observed in a clinical study of another product, and perhaps there may be no reflection In fact, it has been observed.

In a controlled clinical study in the United States, more than 3, 300 subjects with allergic and nonallergic rhinitis were treated for intranasal rhinitis. fluticasone propionate Common adverse effects of Verdin in clinical studies were primarily associated with irritation of mucous membranes. the nasal mucous membranes, and side effects were reported with probably equal frequency for subjects treated with placebo. At least 2% of subjects in the laboratory tests stopped because of adverse effects. This rate was similar for the placebo solution and the intensive comparison product.

The safety data discussed below are based on seven placebo-controlled clinical studies in subjects with allergic rhinitis; the seven studies included 536 subjects (57 girls and 108 boys aged 4 to 11 years, 137 women and 234 men) – adolescents and adults. fluticasone propionate nasal spray Two placebo-controlled clinical studies using 200 mcg once daily for 2 to 4 months and 246 subjects (119 females and 127 males) were treated with 200 mcg once daily for 6 months (Table 1). fluticasone propionate nasal spray 200 mcg once daily for 6 months (Table 1). Table 1 also includes side effects from two studies in which 167 children (45 girls and 122 boys between the ages of 45 and 11) were treated. fluticasone propionate nasal spray 100 mcg once daily for 2-4 months.

Table 1: Adverse Reactions with Fluticasone Propionate Nasal Spray with >For allergic rhinitis 3% more often and more frequently than placebo in subjects over 4 years

Fluticasone propionate 100 mcg once daily (n = 167) %.

Fluticasone propionate 200 mcg once daily (n = 782) % of

Nasal/nasal irritation burning

Other side effects at fluticasone propionate nasal spray Observed with less than 3% frequency, but 1% more frequently than with placebo, including in nasal Mucus, runny nose, abdominal pain, diarrhea, fever, flu-like symptoms, pain, dizziness, bronchitis.

Email Marketing Experience.

In addition to unwanted symptoms reported from laboratory tests, appropriate side effects were found during nasal use fluticasone propionate Because these responses are spontaneously reported from indefinitely sized populations, it is not always possible to estimate their frequency or establish a causal link to product actions. These actions are selected for admission because they report thoroughness, frequency, or causal context. to fluticasone propionate or a combination of these points.

Status of concurrent disorders and mention in admission criteria: angioedema, skin rash, face and tongue edema, teeth, ur measles, bronchospasm, squealing breath, hypersensitivity reactions, including desquamation, anaphylaxis/anaphylaxis reactions, if rare, if rare, if rare, if rare, in rare cases, Hypersensitivity reactions, including anaphylaxis/anaphylaxis reactions, rare if rare, rare if rare, rare if rare, rare if rare, rare if rare

Ear and labyrinth disturbances: change or loss of taste or loss of taste, sometimes, nasal Septal perforation, nasal ulcers, sore throat, laryngeal discomfort, cough, ho voice, voice structure.

Eye disorders: dryness and dissatisfaction, conjunctivitis, blurred vision, glaucoma, hypertrophic intraocular pressure, cataracts.

Cases of elevated suppression include. fluticasone propionate nasal spray [see Warnings and Precautions (5. 7)].

Drug Interactions

Cytochrome P450 3A4 Lemmers.

Fluticasone propionate Is a substrate for CYP3A4; Toediening van Krachtige CYP3A4-REMMERS (Bijv. Ritonavir, Atazanavir, Claritromycine, Indinavir, Itraconazol, Nefazodon, Nelfinavir, Saquinavir, Ketoconazol, Teletromycine, convaptan, nefapinazol)) ))))) fluticasone propionate nasal spray Not recommended due to increased systemic side effects of corticosteroids.

Ritonavir: drug interaction studies fluticasone propionate aqueous nasal spray In healthy subjects, Ritonavir (a potent CYP3A4 inhibitor) can significantly increase plasma cortisol levels. fluticasone propionate Exposure leads to a significant decrease in serum cortisol levels [see Clinical Pharmacology (12, 3)]. Clinically significant drug interactions have been reported during postmarketing use of fluticasone propionate Products containing. fluticasone propionate nasal spray The use of ketoconazole in combination with ritonavir results in systemic corticosteroid effects, including Cushing’s and adrenal suppression syndrome.

Ketoconazole: simultaneous administration of oral inhalation fluticasone propionate (1000 mcg) and ketoconazole (200 mg once daily) resulted in a 1.9-fold increase in plasma fluticasone propionate exposure and lowered plasma – portisol solubility by 45% on the curve (AUC), but had no effect on urinary cortisol excretion.

Use in specific populations

Pregnancy

Insufficient information on the use of of fluticasone propionate nasal spray pregnant women to state the risks associated with the drug. In animals, teratogenicity, which is characteristic of corticosteroids, is observed in rats, mice, and rabbits at subcutaneous maternal toxic doses, where fetal weight and/or skeletal variants of fluticasone propionate According to this, five times less than the equivalent and very appropriate human daily routine dose (MRHDID) (see animal data). fluticasone propionate Only nasal administered by inhalation in rats did not cause teratogenicity of maternal toxic doses equal to MRHDID based on MCG/M 2, although fetal weight was reduced (see animal data). Oral corticosteroid skills mean that mice are more sensitive to the teratogenic effects of corticosteroids than are people.

The calculated risk of nonfatal birth defects and miscarriages in the given population is unknown. All pregnancies have a background risk of birth defects, costs, or other adverse outcomes. In the combined U.S. population, the estimated risks of clinically recognized pregnancies vary from 2% to 4% and from 15% to 20% for clinically recognized pregnancies, respectively.

Information about the population: intro, fluticasone propionate observed in the blood of newborns of successive families.

Animal data: Embryo training studies with pregnant rats and mice administered via the subcutaneous route in the direction of the organogenesis period, fluticasone propionate (MCG/kg/day), which was teratogenic in both species. No observed ad levels (NOAEL) were observed with the nearly equivalent MRHDID (based on MCG/M 2 at a maternal subcutaneous dose of 30 µg/kg/day). Estrog and fetal skeletal variants were observed in fetal mice at doses approximately equivalent to MRHDID (maternal subcutaneous dose of 45 µg/kg/day); NOAEL mice were treated at approximately 0, 3 times the dose of MRHDID (based on MCG/M 2 at maternal subcutaneous dose of 15 µg/kg/day (based on MCG/M 2 at a maternal subcutaneous dose of 15 µg/kg/day).

In a study on embryonic development in pregnant rats, the dose caused a decrease in fetal body via the nasal inhalation pathway throughout organogenesis, fluticasone propionate skeletal formation caused by fetal body weight reduction and stay of maternal toxicity, now at doses equal to MRHDID (based on MCG/M 2, mam-only inhalation dose, element 25, 7 µg/kg/day); however, there was little evidence of teratogenicity; NOE-ELAP was observed at about 0, 25 of MRHDID times the dose observed (5, 5 µg/kg/day in mothers only at the inhalation dose based on MCG/M 2).

In an investigation of embryo formation in pregnant rabbits administered subcutaneously during organogenesis, fluticasone propionate caused fetal weight loss in the presence of maternal toxicity at doses approximately 0.06 times higher than MRHDID (maternal subcutaneous dose 0.57 mcg/kg/day per mcg/m2 ). Teratogenicity was evident as cleft palate was detected in one fetus at a dose 0.39 times that of MRHDID (maternal subcutaneous dose 4 mcg/kg/day per mcg/m2 ). ) of MRHDID in fetal rabbits.

Fluticasone propionate The drug then passed through the placenta by subcutaneous administration to mice and rats and by oral administration to rabbits.

In prenatal and postnatal developmental studies in pregnant rats administered during late gestation and lactation (gestational day 17 to postnatal day 22), fluticasone propionate Double doses of MRHDID (maternal subcutaneous doses up to 50 µg/kg/day, per µg/m2 ) were not associated with pup weight loss and had no effect on developmental stage, learning, memory, reflexes, or reproductive performance.

Breastfeeding

No available available information. of fluticasone propionate Effects in breast milk, on breastfeeding, or on milk production. Low concentrations of other corticosteroids have been detected in breast milk. In addition to the clinical needs of the mother, the benefits of breastfeeding on the infant’s development and well-being should be considered. for fluticasone propionate nasal spray Adverse effects of the breastfeeding program on the infant, the mother, or the underlying function of the mother. fluticasone propionate nasal spray or from the underlying disease of the mother.

Animal data: subcutaneous administration of tritium. fluticasone propionate In lactating rats at a dose of 10 µg/kg/day, measurable values were observed in milk.

Pediatric use

Safety and Efficacy of fluticasone propionate nasal spray Effects in children 4 years and older have not been established [see Adverse Reactions (6. 1), Clinical Pharmacology (12. 3)]. In clinical trials in the U.S., 600 subjects between the ages of 4 and 11 years (650 subjects) and 440 subjects between the ages of 12 and 17 years were tested. fluticasone propionate nasal spray The study was conducted in the U.S. in a clinical trial in the U.S. Protection and Efficacy of fluticasone propionate nasal spray Not established in children under 4 years of age.

Effect on Lifting: Controlled clinical studies have shown that nasal corticosteroids can cause a reduction in lifting velocity when administered to pediatric patients. This effect was observed without a laboratory suppression certificate for the hypothalamus (HPA). This suggests that lift velocity may be considered a more sensitive indicator of the systemic effects of corticosteroids in pediatric patients than the more commonly used studies on HPA as a function. The long-term effects of the gray reduction in ascending velocity associated with nasal corticosteroids, including effects on eventual adult length, have not yet been established. The potential for “catch-up growth” after cessation of treatment with nasal corticosteroids has not been adequately investigated. Increased number of pediatric patients involving nasal corticosteroids fluticasone propionate nasal spray Footsteps are regularly checked (e.g., via stadiometry). The impact of increased healing in the long term should be weighed against the acquired clinical benefits and risks of other therapies. Including fluticasone propionate nasal spray Each patient’s dose should be titrated to the lowest dose that actually keeps their symptoms under control.

A 1-year placebo-controlled study has been conducted with 150 pediatric subjects (3-9 years old) of fluticasone propionate nasal spray (200 mcg once daily) Climbing Rate. of the original population. fluticasone propionate nasal spray (n = 56) and placebo (n = 52) received were point estimates of climbing rate. fluticasone propionate nasal spray 0, 14 cm/year lower than placebo (95% CI: -0, 54, 0, 27 cm/year). Thus, no statistically important effect on rate of ascent compared to placebo was observed. Correspondingly, no evidence of clinically important changes in HPA ash function or bone mineral density was observed, as observed in support of 12-hour urine excretion and dual energy x-ray absorptiometry.

The potential for fluticasone propionate nasal spray Elevated or higher than adequate dose suppression in susceptible patients may not be ruled out.

Elderly.

A limited number of subjects 65 years and older (n = 129) or 75 years and older (n = 11) were treated with supportive care fluticasone propionate nasal spray Clinical examination. Although the number of subjects is very small to conduct another performance and safety test, the side effects reported in this population were comparable to those of younger patients. In general, the greater frequency of decreased liver, kidney, or heart function, concurrent disease, or other pharmacologic therapies should be carefully selected for older patients, usually starting at the bottom of the dosing spectrum.

Take advantage of the impairments

Formal pharmacokinetic testing with the use of fluticasone propionate nasal spray not be performed in individuals with hepatic dysfunction. Enclosed. fluticasone propionate cleared primarily by liver metabolism, liver dysfunction may lead to accumulation of C of fluticasone propionate in plasma. As a result, patients with liver dysfunction should be carefully checked for

renal insufficiency.

Formal pharmacokinetic testing with the use of fluticasone propionate nasal spray Not performed on people with renal insufficiency.

Overdose

Chronic overdose may cause signs/symptoms of hypercortisolism [see Warnings and Precautions (5, 5)]. 2 mg intranasal (10 more appropriate doses) of fluticasone propionate dosed twice daily for 7 days in healthy human volunteers [see Warnings and Precautions (5, 5)]. Side effects reported as fluticasone propionate were comparable to placebo, and no clinically significant abnormalities were observed during laboratory safety testing. In human volunteers without acute toxic effects, a single oral dose of up to 16 mg was studied. With human volunteers, up to 80 mg per day was repeated encephaloabdominally for 10 days and up to 10 mg per day for 14 days in patients. Side effects were little or no problematic, and confrontations were comparable in the intensive placebo group. Acute overdose at this dose is virtually impossible. For example, one bottle of fluticasone propionate nasal spray contains approximately 8 mg of fluticasone propionate .

Fluticasone Nasal Spray Description

The active component of fluticasone propionate nasal spray USP is fluticasone propionate USP, chemical name S(fluorethyl)6α,9-difluoro-11β-17-dihydroxy-16α-methyl-3-oxoandrost-1,4-Service-17β-carbothio, 17 propionic acid and proprietary chemical name:

Fluticasone propionate 500, 6 and molecular formula C 25 H 31 F 3 O 5 S. It is a broken white powder that is insoluble in water, well soluble in dimethyl sulfoxide and dimethyl formamide, poorly soluble in formaldehyde and 95 % ethanol.

Fluticasone propionate nasal spray 50 µg is an aqua suspension of microfidgin. fluticasone propionate For district control the nasal Mucosa spray pump. Fluticasone propionate nasal spray There is still 0, 02% wt./MAS. Benzalkonium chloride, dextrose, microcrystalline cellulose and sodium carboxymethylcellulose, 0. 25% wt./MAS. with phenylethyl alcohol and polysorbate 80, contains a pH of 5 to 7.

After the initial filling, each attack delivers 50 μg of fluticasone propionate through a 100 mg formulation. the nasal adapter.

Fluticasone Nasal Spray – Clinical Pharmacology

Mechanism.

Fluticasone propionate It is a synthetic tri-corticosteroid with anti-inflammatory properties. Fluticasone propionate has been shown in vitro to exhibit a human glucocorticoid sensor binding affinity 18-fold greater than that of dexamethasone. greater than that of budesonide, which is greater than that of budesonide, which is greater than that of budesonide, which is greater than that of budesonide, which is greater than that of budesonide. Field data from the Mackenzie Vasoconstrictor Analysis of People correspond to these results. The clinical significance of these results is unknown.

The exact device fluticasone propionate The symptoms of rhinitis are pronounced. Corticosteroids have been shown to have a wide range of effects on myriad cell types (fertilizer cells, eosinophils, neutrophils, macrophages, lymphocytes, etc.) and mediators (histamine, eicosanoids, leukotrians, cytokines, etc.) In seven adult tests, fluticasone propionate nasal spray has decreased nasal mucosal eosinophils in 66% of patients (35% on placebo) and basophils in 39% of patients (28% on placebo). The unclear association of these results with long-term symptom illumination is unknown.

Pharmacodynamics

Effects on the HPA axis: possibly systemic effects of fluticasone propionate nasal spray The following effects were evaluated on the HPA axis Fluticasone. propionate nasal spray taken once daily, 200 mcg or twice daily, compared to placebo or oral prednisone 7, 5 or 15 mg. Fluticasone. propionate nasal spray Each dose was in the direction of 4 months, so there was no effect on the adrenal response to 6 h cosantropine intra-view micronization, but both doses of oral prednisone significantly reduced the response to cosantropine.

Cardiac electrophysiology: a study specifically designed to assess the effects of fluticasone propionate nasal spray QT No QT was performed on QT breaks.

Pharmacokinetics.

The activity of fluticasone propionate nasal spray Related to parent product, fluticasone propionate Due to low bioavailability via the nasal route, the majority of pharmacokinetic data is obtained through other access roads.

Absorption: indirect calculations indicate that fluticasone propionate Delivered via the nasal route contains an average of less than 2% unconditional bioavailability. Tests involving the implementation of oral doses of labeled and non-labeled substances show oral systemic bioavailability of fluticasone propionate is negligible (<1%), primarily due to incomplete absorption and presystemic metabolism in the gut and liver. After intranasal treatment of patients with rhinitis for 3 weeks, fluticasone propionate Plasma concentrations exceeded detection (50 pg/ml) only when the appropriate dose was exceeded, and then only in random samples with low plasma concentrations.

Distribution: after the first stage of intravenous administration for fluticasone propionate fast, consistent with the highest liposolubility and tissue binding. Spread size averaged 4.2 l/kg.

The percentage of fluticasone propionate Binding to human plasma proteins averaged 99%. Fluticasone propionate Weakly and reversibly bound to erythrocytes, but less so to human transcortin.

Removal: after intravenous administration, fluticasone propionate exhibited polylexic kinetics with a final elimination half-life of approximately 7.8 hours. Blood clearance of fluticasone propionate is high (average: 1.093 ml/min) and renal clearance is less than 0.02% of total volume.

Metabolism: The only circulating metabolite found in humans is the formation of 17β-carboxylic acid of fluticasone propionate This appears via the CYP3A4 pathway. This metabolite has a lower affinity (about 1/2000) than the parent product for the glucocorticoid sensor of non-severe human cytosol in vitro and has had little pharmacological efficacy in animal studies. Other metabolites identified in vitro by transduction of cultured human hepatocellular carcinoma cells have not been detected in humans.

Excretion: Less than 5% of the oral radioactive dose is excreted in the urine as metabolites, the remainder is excreted in the feces as parent products and metabolites.

Special populations: fluticasone propionate nasal spray No special populations have been studied and little sex-specific pharmacokinetic data are available.

Drug: Cytochrome P450 3A4 Inhibitor: Ritonavir: Fluticasone propionate Substrate for CYP3A4. Concurrent administration of fluticasone propionate Ritonavir, a potent CYP3A4 inhibitor, is not recommended based on a multi-crossover drug interaction study in 18 healthy subjects. Fluticasone propionate aqueous nasal spray (200 µg once daily) along with ritonavir (100 mg twice daily) for 7 days. Plasma fluticasone propionate concentrations as follows fluticasone propionate aqueous nasal spray 1 not seen in any patient (

Ketoconazole: simultaneous administration of oral inhalation fluticasone propionate (1000 mcg) and ketoconazole (200 mg once daily) resulted in a 1.9-fold increase in plasma fluticasone propionate Exposure decreased plasma cortisol AUC by 45%, but had no effect on urinary cortisol excretion.

Erythromycin: In a multiple dose interaction study, erythromycin administered in combination with an oral inhaled drug fluticasone propionate (500 mcg twice daily) and erythromycin (333 mg three times daily) had no effect. fluticasone propionate pharmacokinetics.

Non-clinical toxicology

Carcinogenicity, mutagenesis, fertility issues

Fluticasone propionate 78 months or in the direction of the rat, based on this, based on this, based on this, based on this, based on this, based on this, based on this, based on this, based on this, based on this, based on this, based on this, there was no indication of carcinogenic potential in mice during oral administration up to about 25 and over 20) over MRHDID in adults and boys during the inhalation phase up to 57-57-57-57-57-57-57 57-57-57-57-57-57-57-57-57 mcg/kg (approximately 3 and 2 times that of MRHDID in adults and boys, along with this, MCG/M 2) based on a 104-month direction.

Fluticasone propionate No genetic mutations were induced in prokaryotic or eukaryotic cells in vitro; no significant blastocyst viability effects were observed in cultured human peripheral lymphocytes or mouse micronucleus tests in vitro.

Fertility and reproductive characteristics were unaffected in male and female rats at subcutaneous doses of up to 50 µg/kg (approximately twice the MRHDID in adult MCG/M 2 based rats).

Clinical Research

Long-term nonallergic rhinitis: 3 randomized, double-blind parallel group, vehicle placebo-controlled checks were performed on 1191 subjects for studies on continued use. of fluticasone propionate nasal spray in subjects with long-term nonallergic rhinitis. These checks studied a continuous and ongoing population of subjects nasal including characteristic scores (TNS). nasal Obstruction, tumor posterior drop, and thymus treated in subjects described in the direction of 28 days of double-blind therapy were treated in three studies in the direction of 6 months of treatment by published labeling. Two of these studies showed that subjects were treated fluticasone propionate nasal spray (100 mcg twice daily) showed a statistically significant reduction in TNS compared to subjects treated with medium.

Delivery/ Preservation and Treatment Methods

Fluticasone Propionate Nasal Spray USP, 50 mcg, is supplied in a white colored pump, white, white glass bottle. nasal The Adapter is equipped with a colorless plastic dust cap and a green-like safety clip in a box with an FDA approved patient sign (see patient application note for correct use of device). Each bottle has a 16 g uncertain filling agency, assuring 120 timely actions. Each exposure provides 50 µg of fluticasone propionate through a 100 mg formulation. the nasal adapter. Each appropriate number of medical preparations spray Then there is no possibility of becoming undisputed 120 sprays although the bottles are not completely empty. The marked number system should be applied and the bottle discarded.

Store 4° to 30°C (39° and 86°F).

Information on Patient Guidance

Advise patient to read label approved by FDA (Patient Information and Instructions).

Topical nasal effects: advise patient to cure fluticasone propionate nasal spray May lead to side effects such as epistaxis and nasal Ulcers. Candida infections can occur even when treated with supportive care. fluticasone propionate nasal spray . In addition, fluticasone propionate nasal spray Associated with nasal Septaire perforation and noncompliance with wound healing. Patients who have recently nasal ulcers, nasal surgery, or nasal trauma should not use fluticasone propionate nasal spray recovery occurred [see Warnings and Precautions (5. 1)].

Glaucoma and cataract: Inform patients that glaucoma and cataract are associated with corticosteroid use. nasal Inhaled corticosteroid use. Advise patients to alert their care providers if they notice changes in vision while using corticosteroids. fluticasone propionate nasal spray [See Warnings and Precautions (5. 2)].

Hypersensitivity reactions, including anaphylaxis: Inform patients that hypersensitivity reactions such as anaphylaxis, angioedema, ur measles, contact dermatitis, and skin rash may occur after administration. of fluticasone propionate nasal spray Velds these reactions occur, the patient should terminate use. of fluticasone propionate nasal spray [See Warnings and Precautions (5. 3)].

Immunosuppression: warn patient to avoid the effects of water cell or measles by using corticosteroid doses of immunosuppressive agents. Inform patient about the possibility of reversal of existing tuberculosis. Fungal, bacterial, viral, or parasitic infections; or herpes simplex (see Warnings and Precautions (5. 4)).

Decreased rate of ascent: advise the caregiver about what fluticasone propionate nasal spray Decreased rate of ascent can cause pediatric patients during dosing. Physicians have a duty of care to supervise the release of children and adolescents who use corticosteroids via any route [see Warnings and Precautions (5. 4)]. Warnings and Precautions (5. 7), Pediatric Referral (8. 4)].

Use daily for best effect: inform patient appropriately use fluticasone propionate nasal spray Should be used continuously. Fluticasone. propionate nasal spray As with other corticosteroids, has no special effect on rhinitis symptoms. May not reach ultimate benefit within a few days. Patients are not obligated to increase the prescribed dose, but they are not obligated to consult a physician if symptoms do not improve or if the situation worsens.

Keep spray away from eyes and mouth: inform patients not to spray fluticasone propionate nasal spray to their eyes and mouth to avoid.

Disk. Author: West

Eatontown, NJ 07724

Verify December 2019

Patient Information.

Fluticasone Propionate Nasal Spray USP, 50 mcg

(floo tik ‘sone proe’ pee oh nate)

What is fluticasone propionate nasal spray ?

Fluticasone propionate nasal spray Recipe drug used to treat non-allergic nasal Runny nose, stuffy nose, sneezing, etc. and nasal Itching in adults and children from 4 yrs. old.

It is not known if fluticasone propionate nasal spray Safe and effective for children under 4 yrs.

Do not use fluticasone propionate nasal spray if you are allergic to fluticasone propionate Or one of the ingredients in fluticasone propionate nasal spray See “Which Ingredient? in fluticasone propionate nasal spray below for a complete list of ingredients.

Before using fluticasone propionate nasal spray Tell your own health care provider about all your ailments, in case you have any.

• have or have had nasal sores, nasal surgery, or nasal I have eye problems such as glaucoma or cataracts. -Immune system problems. It is unknown. if fluticasone propionate nasal spray Can be harmful to your unborn child. This unknown if fluticasone propionate nasal spray It is unknown if it ends up in breast milk and if it is harmful to your baby.

Tell your doctor about all medications you use, including prescription and freely available medications, vitamins, and herbal supplements. Fluticasone. propionate nasal spray and several other medications can interact with each other. This can cause serious side effects.

Inform your own medical supplier if you are using antifungal or anti-HIV medications.

Know what medications you are using. When you get new medications, keep a list to show your own medical supplier and pharmacist.

How should I use fluticasone propionate nasal spray ?

Read the Step – Step User Manual fluticasone propionate nasal spray At the end of this patient information.

• Fluticasone propionate nasal spray Use only with the nose. Do. not spray In your eye or in your mouth. Babies must be use fluticasone propionate nasal spray With the assistance of an adult baby, as your care provider stipulates. Use fluticasone propionate nasal spray Exactly as your caregiver tells you. Not use fluticasone propionate nasal spray more often than indicated. Fluticasone. propionate nasal spray It may take several days for rhinitis symptoms to improve. If symptoms do not improve or worsen, contact your doctor. fluticasone propionate nasal spray Regularly, daily, without skipping doses. If you begin to feel better than normal, your doctor may reduce the dose. Do not stop using it! fluticasone propionate nasal spray unless your doctor has told you that you should.

What are the possible side effects? of fluticasone propionate nasal spray ?

Fluticasone propionate nasal spray It can cause serious side effects, including

– Nasal problems. Nasal problems consist of: – Nasal bleeding. -Nasal zwaren (pain). nasal (Septal perforation). Symptoms of nasal Partition perforation can cause, among others, – scabbing of the nose – nasal bleeding – runny nose – blowing mouth whi when breathing – slow healing of the wound. You should not use fluticasone propionate nasal spray undergo nasal correction if you have a painful nose until the nose heals, or if your beak is injured, glaucoma and cataracts. With the use of nasal inhaled corticosteroids, you may develop glaucoma and/or cataracts. Your care provider can take you to a doctor (ophthalmologist) if you develop signs of eye disease or cataracts. use fluticasone propionate nasal spray longer period of time. Tell your care provider if you are using it and if you are suffering from eye configurations fluticasone propionate nasal spray Porem – an unusual allergic reaction. Call your caregiver or find the medical help you need if you get one of the correct symptoms of a serious allergic reaction: – rashes – hives – swelling of the face, mouth, and tongue – difficulty breathing – weakened immune system and increased risk of infection). Taking medications that weaken the immune system increases the likelihood of infection and may aggravate certain infections. These infections include tuberculosis, herpes simplex infections, and infections caused by fungi, bacteria, microorganisms, and parasites, which carry a higher risk. When using the product, be careful to avoid contact with people who have chickenpox, measles, or other contagious diseases fluticasone propionate nasal spray Call your care provider immediately if you come in contact with someone who has chickenpox or measles. Signs of infection include. -Fever – Feeling countless. Adrenal deficiency, when the adrenal glands do not produce enough steroid hormones. This can occur when stopping taking oral corticosteroids (such as prednisone) and starting medications containing inhaled corticosteroids (such as inhaled corticosteroids. as fluticasone propionate nasal spray ) adrenal glands) Symptoms include the following Lifting the baby’s footsteps often tests.

The most well-known side effects are of fluticasone propionate nasal spray include:

– Headache – Popularity and nausea – Sore throat – Difficulty breathing – Bloody nose – Cough – Nose or itching

These are not all possible side effects! fluticasone propionate nasal spray .

Ask your own doctor about side effects; you can report side effects to the FDA at 1-800-FDA-1088.

How do I take Fluticasone Propionate Nasal Spray?

• Store fluticasone propionate nasal spray 39° to 86°F (4° and 30°C).

Keep fluticasone propionate nasal spray And all medications are out of the reach of children.

General information on non-toxic and effective use of fluticasone propionate nasal spray .

Medications may be prescribed for purposes not listed in the package leaflet. There are no use fluticasone propionate nasal spray For conditions for which it is not prescribed. Do not give them to you. fluticasone propionate nasal spray to others, even if they have the same condition as you. This could cause them harm.

You can ask your public pharmacist or health care employee for information about your medications. fluticasone propionate nasal spray This is written for health care employees.

Which Ingredients in fluticasone propionate nasal spray USP?

Active ingredient: fluticasone propionate USP.

Inactive ingredients: 0, 02% wt./MAS. benzalkonium chloride, dextrose, microcrystalline cellulose and sodium carboxymethylcellulose, 0, 25% wt./MAS. phenyl alcohol and polysorbate 80.

For more information. fluticasone propionate nasal spray Call 1-800-962-8364.

Disk. Author: West

Eatontown, NJ 07724

Verify December 2019

Instructions for use.

Fluticasone Propionate Nasal Spray USP, 50 mcg

(floo tik ‘sone proe’ pee oh nate)

Fluticasone propionate nasal spray For nasal use only.

Read this information before use fluticasone propionate nasal spray .

Your fluticasone propionate nasal spray Before using for the first time, you must fill if you have not used for more than one week.

How to prime your fluticasone propionate nasal spray :

– Shake the bottle carefully, then remove the dust cover and clamp (Figure 1).

– Hold the bottle as shown (Figure 2). the nasal The applicator will reject you, and your index and middle fingers on either side of the the nasal thumb under the applicator and the bottle. Print six times on the applicator until fine spray appears (Figure 2). The pump is now ready for use.

Using your fluticasone propionate nasal spray :

Step 1: Sniff to clean nostrils.

Step 2: Stop 1 nostril closed. Tilt head slightly forward and hold bottle upright. the nasal applicator for the other nostril (Figure 3).

Step 3: Start fan through nose, press applicator well and let go once. the spray To obtain a perfect dose, use index and middle fingers. to spray Support the base of the bottle with your thumb. Note that you are spraying into the eyes. Breathe through nostrils (Figure 4).

Step 4: Exhale through the mouth.

Step 5: For the second spray Repeat steps 2-4 for this nostril.

Step 6: Repeat steps 2 through 5 with the other nostril.

Step 7 : Wipe the nasal Cover the applicator with an uncomfortable cloth and replace the dust protector and clip to assure safety (Figure 5).

Do not use this bottle longer than the number specified. of sprays Even if the bottle is not completely empty. Before discarding the bottle, you should consult your health care provider, regardless of whether a new dose is needed. Do not finish the medication without taking the booster dose fluticasone propionate nasal spray without consulting with your health care provider.

Cleaning your fluticasone propionate nasal spray :

Your nasal spray You should refill at least once a week.

1. remove dust cap and carefully pull up for free cleaning the nasal applicator.

2. wash applicator and dust cover under warm tap water. Allow to dry at room temperature. 3.

3. return the applicator and dust cover to the bottle.

4. If the nasal The applicator is lockable and can be sent and forgotten soaking in warm water. Was. the nasal applicator equipped with cold tap water. Dry. the nasal applicator and return it to the bottle. Do not unlock the the nasal applicator by inserting a pin or another sharp object.

Storing your fluticasone propionate nasal spray :

– Save between 39° and 86°F (4° and 30°C). Do not use fluticasone propionate nasal spray after the “Express” date on the label or box.

This Patient Information and Use Bill of Sale has been approved by the U.S. Food and Drug Administration.

Disk. Author: West

Eatontown, NJ 07724

Verify December 2019

Panel Shield – Package/Label

Product Information
Type.Recipe for People Drug LabelDust Code (Source)NDC: 0054-3270
AdministrationNasalDEA Schedule
Active Component/ Active Ingredient
Name ComponentStrength based onCourage
FluticasonPropionate (fluticasone)Fluticasone Propionate50 mcg
Inactive Ingredients
Name ComponentCourage
Benzalkonium chloride
Sodium carboxymethylcellulose, indeterminate
Microcrystalline cellulose
Dextrose, indeterminate form
Phenylethyl alcohol
PolySorbaat 80
Package
#Product CodeDescription Package
1NDC: 0054-3270-991 bottle, 1 glass, 1 box
1Measured in 12 sprays, 1 bottle, glass
Marketing Information
Marketing CategoryOrder number or quoted monographMarket Start DateEnd date marketing
and aANDA07650422. 02. 2006
Lakelair-West-Ward Pharmaceuticals Corp.(080189610)
Institution
NameAddressID/FEIActivity
Wes t-Ard Columbus Inc.058839929Production (0054-3270)

Wes t-Ard Pharmaceuticals Corp.

More about fluticasone nasal

  • Please review the interactions
  • Compare alternatives
  • Prices and Coupons
  • Reviews (316)
  • Recent FDA Warnings (1)
  • Side Effects
  • Dosing Information
  • Advice for Patients
  • Pregnancy
  • Drug class: nasal steroids
  • In Spanish

Patient Source

Tools for Professionals

✒ Last Updated: September 22, 2023
⛑ Medical Practice


About TSMP


Family Medicine

Family Medicine

In 2023, our team of doctors and nurses provide a comprehensive range of family planning services. Our doctors have expertise in antenatal care, preconception planning, and STD checks. Contraceptive advice, including Mirena and Implanon insertion, is available.

  • Early detection of illness;
  • Family planning;
  • Promotion of healthy lifestyle;
  • Skin cancer checks;
  • Sports injuries;
  • Weight reduction;
  • Workers compensation and third party.

Children's Health

Children's Health

Baby Weighing Service. Babies can be booked with our Nurse for weighing. A doctor's appointment is not required to use this service-contact reception for an appointment to have your baby entertained.

Immunizations. At Tuggeranong Square, immunization is essential to your child's health care. Our doctors take immunizing children very seriously. Tuggeranong Square Medical Practice doctors BULK BILL for all children's immunizations to ensure all children are immunized. Tuggeranong Square Medical Practice also ensures the Practice Nursing Staff are highly trained in childhood immunizations.


Women's Health

Women's Health

Our practice treats a wide spectrum of women’s health concerns. We offer pre-natal, antenatal, and postnatal care, contraceptive options, pap screening, and preventative health care advice. We provide assistance, advice, and support through all stages of life, recognizing the many issues many women may face from adolescence through to the peri and post-menopausal periods.

  • Cervical Screening tests;
  • Reproductive health. Including Mirena and Implanon insertion;
  • Shared antenatal care.

Men's Health

Men's Health

We encourage men to present routinely to their GP to discuss all aspects of their health. We provide comprehensive advice and support for men to address the prevention and management of various health conditions. This may include assessments for cardiovascular risk, diabetes, cancer prevention, mental health assessments, STD screening, sports injuries, and the importance of sleep as it relates to other areas of health.

  • Preventative Healthcare. Including cardiovascular screening, mental health, and cancer checks;
  • Prostate examination.
Alex Koliada, PhD

By Alex Koliada, PhD

Alex Koliada, PhD, is a well-known doctor. He is famous for his studies of ageing, genetics and other medical conditions. He works at the Institute of Food Biotechnology and Genomics NAS of Ukraine. His scientific researches are printed by the most reputable international magazines. Some of his works are: Differences in the gut Firmicutes to Bacteroidetes ratio across age groups in healthy Ukrainian population [BiomedCentral.com];Mating status affects Drosophila lifespan, metabolism and antioxidant system [Science Direct];Anise Hyssop Agastache foeniculum Increases Lifespan, Stress Resistance, and Metabolism by Affecting Free Radical Processes in Drosophila [Frontiersin]. Read more about the author.